- Home
- ENTA vs PCB Comparison
ENTA vs PCB Comparison
Compare ENTA & PCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- PCB
- Stock Information
- Founded
- ENTA 1995
- PCB 2003
- Country
- ENTA United States
- PCB United States
- Employees
- ENTA N/A
- PCB N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- PCB Major Banks
- Sector
- ENTA Health Care
- PCB Finance
- Exchange
- ENTA Nasdaq
- PCB Nasdaq
- Market Cap
- ENTA 316.2M
- PCB 302.0M
- IPO Year
- ENTA 2013
- PCB N/A
- Fundamental
- Price
- ENTA $12.65
- PCB $21.71
- Analyst Decision
- ENTA Strong Buy
- PCB Hold
- Analyst Count
- ENTA 6
- PCB 2
- Target Price
- ENTA $20.33
- PCB $24.50
- AVG Volume (30 Days)
- ENTA 387.8K
- PCB 31.2K
- Earning Date
- ENTA 11-17-2025
- PCB 10-23-2025
- Dividend Yield
- ENTA N/A
- PCB 3.69%
- EPS Growth
- ENTA N/A
- PCB 43.50
- EPS
- ENTA N/A
- PCB 2.41
- Revenue
- ENTA $65,324,000.00
- PCB $107,743,000.00
- Revenue This Year
- ENTA $2.13
- PCB $21.55
- Revenue Next Year
- ENTA $2.74
- PCB $8.65
- P/E Ratio
- ENTA N/A
- PCB $8.99
- Revenue Growth
- ENTA N/A
- PCB 13.61
- 52 Week Low
- ENTA $4.09
- PCB $16.00
- 52 Week High
- ENTA $15.34
- PCB $22.45
- Technical
- Relative Strength Index (RSI)
- ENTA 66.08
- PCB 56.46
- Support Level
- ENTA $11.89
- PCB $20.87
- Resistance Level
- ENTA $13.00
- PCB $21.81
- Average True Range (ATR)
- ENTA 0.83
- PCB 0.44
- MACD
- ENTA 0.09
- PCB -0.03
- Stochastic Oscillator
- ENTA 80.78
- PCB 54.49
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.